Plerixafor and Septic shock - a phase IV clinical study of FDA data

Summary:

Septic shock is reported as a side effect among people who take Plerixafor (plerixafor), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Cytarabine, and have Acute myeloid leukaemia.

The phase IV clinical study analyzes which people have Septic shock when taking Plerixafor. It is created by eHealthMe based on reports of 694 people who have side effects when taking Plerixafor from the FDA, and is updated regularly.

What is Plerixafor?

Plerixafor has active ingredients of plerixafor. eHealthMe is studying from 694 Plerixafor users. Check the latest studies of Plerixafor.

What is Septic shock?

Septic shock (shock due to blood infection) is found to be associated with 1,728 drugs and 3,400 conditions by eHealthMe. Check the latest studies of Septic shock.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jul, 16, 2026

694 people reported to have side effects when taking Plerixafor.
Among them, 17 people (2.45%) have Septic shock.

Among these 17 people:

How long have people been on Plerixafor when they have Septic shock? *

What is the gender of people who have Septic shock when taking Plerixafor? *

female: 25 %
male: 75 %

What is the age of people who have Septic shock when taking Plerixafor? *

What are other drugs people take besides Plerixafor? *

What are other side effects people have besides Septic shock? *

Febrile Neutropenia (fever with reduced white blood cells): 7 people, 41.18%
Pneumonia: 4 people, 23.53%
Fever: 3 people, 17.65%
Stomatitis (inflammation of mucous membrane of mouth): 3 people, 17.65%
Neuropathy Peripheral (surface nerve damage): 2 people, 11.76%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 2 people, 11.76%
Gastrointestinal Inflammation (inflammation of stomach and intestine): 2 people, 11.76%
Bone Pain: 2 people, 11.76%
Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 2 people, 11.76%
Infection: 2 people, 11.76%

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 9 people, 52.94%
Multiple Myeloma (cancer of the plasma cells): 4 people, 23.53%
Haematopoietic Stem Cell Mobilisation: 2 people, 11.76%
Diffuse Large B-Cell Lymphoma Stage Iv (cancer of b cells, a type of white blood cell-stage iv): 2 people, 11.76%
Metastases To Liver (cancer spreads to liver): 2 people, 11.76%
Blood Pressure Abnormal: 1 person, 5.88%
Depressed Mood: 1 person, 5.88%
Diarrhea: 1 person, 5.88%
Disease Progression: 1 person, 5.88%
Febrile Neutropenia (fever with reduced white blood cells): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Plerixafor and have Septic shock?

- Check whether Septic shock is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Plerixafor:

Plerixafor (694 reports)

Septic shock treatments and more:

Septic shock (51,128 reports)

Browse all side effects of Plerixafor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Septic shock:

Septic shock (1,728 drugs)

Browse all the conditions that are associated with Septic shock:

Septic shock (3,400 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on plerixafor (the active ingredients of Plerixafor) and Plerixafor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.